INTRODUCTION
Moraxella catarrhalis is a Gram-negative human pathogen that causes respiratory tract infections. The species is found as a commensal in pre-school children and causes approximately 15-20% of acute otitis media (AOM) cases. M.
catarrhalis is also the third most common cause of exacerbations in patients with chronic obstructive pulmonary disease (COPD) after Streptococcus pneumoniae and Haemophilus influenzae.
1 M. catarrhalis adheres to and infects pulmonary epithelial cells, and has been found to hide in the palatine tonsils. 2, 3 Since the 1980s more than 97% of M. catarrhalis strains have been -lactamase positive. 4 In parallel with most other Gram-negative bacteria, M. catarrhalis releases outer membrane vesicles (OMV), which are small spheres secreted from the outer membrane as the membrane bulges out and pinches off. The OMV thus reflect the composition of the outer membrane; carrying mainly lipids, outer membrane proteins but also DNA. [5] [6] [7] [8] As the secretion of OMV is an energy-demanding process, it has been suggested that this is an essential virulence mechanism for Gram-negative bacteria. Evidence from various studies supports this notion, as OMV not only have a role in pathogenesis, but also in biofilm formation, nutrient acquisition as well as horizontal gene transfer. 7, [9] [10] [11] OMV interact both with host cells and with other bacteria residing in a mutual niche. Moreover, OMV act as vehicles for secretion of proteins and DNA, whereby these components are protected from destruction and delivered to target cells at a distance. 5, 8, 12 We recently showed that OMV from β-lactamase positive M. catarrhalis also contain the enzyme and consequently absorb and hydrolyze amoxicillin. 13 -lactamase is known as a periplasmic enzyme, and therefore the storage in OMV and subsequent secretion would potentially be an important virulence mechanism. 14 Since
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M. catarrhalis often is found with other bacterial species, 15 we hypothesized that conferral of antibiotic resistance to susceptible bacteria might make co-infection a highly advantageous mechanism also for other species. Intriguingly, we found that -lactamase positive M. catarrhalis OMVs confer resistance to amoxicillin-susceptible H. influenzae and S. pneumoniae in addition to the nowadays rare β-lactamase negative M. catarrhalis.
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The antibody levels against major Moraxella outer membrane proteins such as
Moraxella IgD-binding protein (MID)/ hemagglutinin (Hag) and Ubiquitous surface proteins (Usp) A1 and UspA2 have previously been studied in both adults and children. [16] [17] [18] IgG levels are generally lower in children compared to adults, leading to a higher incidence of infections in children. However, the human antibody response to M. catarrhalis -lactamase is currently unknown. In the present study, we determined
IgG levels against Moraxella -lactamase in healthy adults using recombinant protein.
A group of individuals that have significant anti--lactamase IgG titres was identified, and these polyclonal antibodies (pAb) recognized -lactamase positive OMV.
Interestingly, we discovered that the hydrolyzing -lactamase activity was partially protected within the OMV. This suggests that Moraxella OMV not only play a role in polymicrobial infections but also act as protective reservoirs for -lactamase, 13 avoiding neutralization by the host adaptive immune system.
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MATERIAL AND METHODS
Bacterial strains and growth conditions. M. catarrhalis clinical and reference strains KR526 and Bc5, respectively, were cultured on chocolate agar plates. Bacteria were grown at 37 °C in 5% CO 2 . To determine MIC for amoxicillin, both Etests (Biodisk, Solna, Sweden) and colony counting (colony forming units; cfu)
after growth in liquid media with varying antibiotic concentrations were used.
Production of recombinant -lactamase, UspA1, A2 and MID. The manufacture of full-length recombinant -lactamase 26-318 from M. catarrhalis strain RH4 was done as described previously. 13 Briefly, the -lactamase bro gene was cloned into the vector pET26b(+), and after selection in E. coli DH5, the protein was produced in E. coli
BL21(DE3) by induction with isopropyl-1-thio--D-galactoside (IPTG). Bacteria
were sonicated and proteins were purified using affinity chromatography. Isolation of M. catarrhalis outer membrane vesicles (OMV). OMV were isolated according to the method described by Rosen et al. 19 Briefly, bacteria were grown in brain heart infusion (BHI) broth overnight at 37°C while shaking, and after centrifugation the resulting supernatant was filtered through 0.2 μm pore-size filters (Sartorius, Goettingen, Germany) to obtain a cell-free solution. The flow through was filtered with 100 kDa Vivaspin centrifugal concentrators (Vivascience, Hannover, Germany). The remaining concentrate was further concentrated by ultracentrifugation at 100,000 x g and washed with phosphate-buffered saline (PBS) followed by centrifugation. The protein concentration was measured using NanoDrop (NanoDrop Technologies, Wilmington, DE), and plated on chocolate agar plates in order to confirm that the preparations were free from bacteria. 
Transmission electron microscopy (TEM)
.
Enzyme-linked immunosorbant assay (ELISA).
To analyze antibody concentrations in serum, ELISA was done as described previously. 17 Briefly, 96-well plates (NUNC, Roskilde, Denmark) were coated with 1 g recombinant protein (UspA1/A2, MID or β-lactamase) per well in Tris-HCl buffer (pH 9.0) overnight at 4°C. After washing and blocking steps, human sera from healthy blood donors (n=40; ages 18-65 years) were added in duplicates for 1 h at RT. Horse-radish peroxidase (HRP)-labelled anti-human IgG polyclonal antibodies (pAb) (1:6,000) (DAKO, Glosterup, Denmark) was added as a secondary layer to plates for 20 min, and after subsequent washing steps the plates were developed and measured at OD 450 . Each sample was tested in duplicate.
Purification of human anti--lactamase IgG. Human sera were purified against a recombinant β-lactamase from M. catarrhalis strain RH4 on a CnBrSepharose coupled column (VWR International, Leicestershire, UK) as described. 
SDS-PAGE and western blotting.
To check the binding of purified anti--lactamase IgG to the recombinant RH4 -lactamase, SDS-PAGE (12%) and western blots were performed. Proteins were transferred from gels to Immobilon-P 8 membranes (Millipore, Bedford, MA) at 20V overnight, and following transfer the membranes were blocked with 5% milk in PBS containing 0.1% Tween (PBSTween). After subsequent washing with PBS-Tween, the membranes were incubated with anti--lactamase pAb purified from normal human serum or rabbit for 1 h at RT as described previously. 17 After several washing steps, membranes were incubated for 1 h with HRP-conjugated secondary rabbit anti-human or swine anti-rabbit pAb (DAKO) respectively, that were diluted 1:1,000. Membranes were washed and developed using enhanced chemiluminescence western blot detection reagents (Amersham Pharmacia Biotech, Uppsala, Sweden).
Determination of the inhibitory effect of serum anti--lactamase
antibodies blocking -lactamase activity in M. catarrhalis OMV. The enzyme activity in OMV was quantified through a nitrocefin assay as previously described. 13 The chromogenic cephalosporin nitrocefin (Oxoid, Thermo Scientific, Cambridge, UK) was used. Briefly, OMV (0.3 g/mL) were pre-incubated with saponin (0.2%) for 5 min at RT to lyse OMV (20) , 20 and incubated with purified anti-β-lactamase pAb isolated from normal human serum or the flow through control serum (dilution 1:10) for 1 h at RT. OMV were incubated with nitrocefin (500 g/mL) for 30 min at 37°C in the dark, followed by centrifugation at 13,000xg for 3 min. After chromogenic hydrolysis the subsequent colour change was determined using 
RESULTS
Outer membrane vesicles from M. catarrhalis carry -lactamase in vivo.
We have recently shown that Moraxella releases OMV that are loaded with -lactamase. 13 To determine whether -lactamase is also associated with OMV in vivo, a specimen obtained with a nasopharyngeal swab from a 9-year old child with Moraxella sinusitis was analyzed by transmission electron microscopy (TEM). As can be seen in Figure 1A , M. catarrhalis readily released OMV in the nasopharynx.
To manufacture specific detection antibodies for M. catarrhalis -lactamase,
we produced a full-length recombinant -lactamase showed a large variation between individuals, and titres were found to be significantly lower than the average anti-UspA1/A2 IgG titres, but higher than the mean anti-MID 962-1200 IgG titres. The high antibody titres for UspA1 and A2 were in parallel with results previosuly obtained in our laboratory. 17 Finally, sera from the healthy donors in general contained higher mean antibody levels against UspA1 as compared to UspA2 (>0.5-fold difference).
To confirm the specificity of anti--lactamase IgG, binding of antibodies against our recombinant -lactamase 26-318 was analyzed by ELISA. An example can be seen in Figure 2B , where we show a serum that bound to -lactamase 26-318 in a dose-dependent manner when compared to a non-binding serum. Intriguingly, out of the 40 patients, only six sera (15.0%) were detected positive for anti--lactamase IgG.
When the human sera were compared in detail, we found that sera with either high or low titres of antibodies against -lactamase (n=3 of each) had equal levels of IgG against MID and UspA1/A2 in both groups (Figure 2c ). In conclusion, no correlation was found between anti--lactamase and anti-UspA1/A2 IgG antibody titres.
OMV protect the -lactamase from specific anti--lactamase IgG. Since we previously have found that -lactamase is associated with OMV, 13 we wanted to investigate whether human anti--lactamase IgG may inhibit the enzyme activity.
Specific antibodies were affinity purified on a Sepharose column containing recombinant -lactamase . The resulting anti--lactamase IgG efficiently detected recombinant -lactamase and was comparable with the rabbit anti--lactamase pAb as shown in western blot (Figure 3a) .
To analyze whether the purified human IgG has the capacity to recognize -lactamase-loaded OMV, we included flow cytometry in our analysis. Anti--lactamase IgG significantly detected OMV isolated from the -lactamase positive M.
catarrhalis KR526 (Figure 3b) . A 5.6-fold increase in mean fluorescence intensity (MFI) was observed with strain KR526 OMV compared to the control with the FITCconjugated secondary detection antibody only (Figure 3c ). In contrast, no binding was seen with the -lactamase negative strain Bc5.
To investigate whether the anti--lactamase antibodies inhibit the enzymatic activity of -lactamase, OMV were incubated with purified anti--lactamase IgG for 1 h to allow binding. Thereafter, -lactamase activity was measured using the chromogenic substrate nitrocefin. When OMV were incubated with anti--lactamase IgG, the enzyme activity decreased with 60.8%±19.6%, confirming that antibodies partially inhibited -lactamase activity in the OMV (Figure 3d ). However, since there still was a significant enzymatic activity in the OMV preparation, vesicles were 
DISCUSSION
Outer membrane vesicles were first observed in the 1970s, 21 and since then increasing evidence has emerged showing that these small spheres play an important role in both bacterial survival and pathogenesis. 6 In the present study, we show that OMV not only act as protective vesicles, whereby proteins can be delivered in complex with other cellular material, but are also important factors in the interplay between bacteria and the host humoral immunity.
We have previously determined the presence of -lactamase in M. catarrhalis OMV, and showed that these OMV confer antibiotic resistance to amoxicillinsusceptible M. catarrhalis, S. pneumoniae and H. influenzae. The latter two species are important pathogens causing AOM and exacerbations in COPD patients. M.
catarrhalis is often isolated as a co-pathogen in infections with S. pneumoniae and H.
influenzae. We suggest that Moraxella has an important role in protecting its copathogens in the upper respiratory tract, by helping them resist antibiotic treatment.
Interestingly, electron microscopy analysis of a nasopharyngeal sample from a child with sinusitis caused by M. catarrhalis, contained the enzyme -lactamase. This further proves that -lactamase is also found in or associated with OMV in vivo, providing a clinical relevance for the vesicles in spreading of antibiotic resistance.
We also show that there is an immunological response against -lactamase as revealed by serum analysis. When IgG levels in sera obtained from healthy adults were compared, it was found that 15% carried anti--lactamase IgG. We analysed specific anti--lactamase IgG levels using recombinant -lactamase produced in E.
coli, and observed higher antibody titres against -lactamase as compared to titres against MID. In contrast, significantly lower antibody titers existed against -lactamase when compared to anti-UspA1/A2 IgG titres. This suggests that UspA1, in contrast to MID, contains immunogenic epitope(s), generating a strong serological response. It has to be kept in mind, however, that the truncated MID 962-1200 is considerably shorter than the UspAs, and represents only a small portion of the large MID molecule. Nevertheless, it seems that β-lactamase is significantly less immunogenic compared to UspA1/A2. To our knowledge, this is the first report on -lactamase antibodies in serum against M. catarrhalis. Taking into consideration that M. catarrhalis -lactamase is a unique enzyme that is highly conserved within the species, 22 we assume that these antibodies were specific for Moraxella -lactamase.
In a paper by Giwercman et al., 23 the levels of -lactamase in cystic fibrosis (CF) patients with Pseudomonas aeruginosa infections were analyzed. These authors found that the -lactamase activity in sputum was high in CF patients, and that levels significantly increased in patients treated with certain antibiotics. In a more recent paper the presence of IgG against chromosomal -lactamase in serum and sputum samples of CF patients was demonstrated. 24 In healthy controls, no anti--lactamase
IgG was detected. The authors speculate that antibodies could potentially affect the efficiency of the treatment by inhibiting the -lactamase present in serum, and thereby contributing some degree of protection against infection.
In our study, anti--lactamase IgG from sera obtained from healthy adults were found to bind to OMV carrying -lactamase. However, a significant enzyme activity still remained in vesicles after incubation with antibodies, indicating that OMV protected the enzyme from inhibition. In the light of the observations made by M. catarrhalis was considered a harmless commensal for a long time.
Although invasive disease may occur, evidence shows that Moraxella is mainly involved in AOM as well as in exacerbations of COPD patients, rendering it a genuine respiratory pathogen. 25, 26 With the introduction of a pneumococcal conjugate vaccine the relative frequency of isolating Moraxella as a pathogen has also increased, suggesting a shift in the bacterial niche. 1, 18 We suggest that another important role for Moraxella is by means of OMV, to provide an advantageous environment for other more severe disease-causing bacteria. Our results clearly show that specific IgG exists against -lactamase in healthy donors, but also that OMV protect the periplasmic -lactamase residing inside OMV from inhibition by antibodies.
Bacterial resistance against antimicrobial agents is an emerging problem, and it is of highest importance to take into account all aspects of the field. The present study may be an impetus for further studies on the role of OMV in infections of antibiotic resistant bacteria. It is highly relevant to in detail examine these mechanisms considering the long-term goal to find new ways of antimicrobial therapy. 
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